#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac failure acute Brain injury Hyperphagia Paget's disease of the vulva Narcolepsy Huntington's disease Gastrooesophageal cancer Hypophosphatasia Astrocytoma Rosai-Dorfman syndrome Acquired haemophilia Alpha-1 antitrypsin deficiency T-cell type acute leukaemia Kawasaki's disease Aicardi-Goutieres syndrome More trials…

    Learn about Rare Diseases

    Haemolytic uraemic syndrome – Trials in Disease Factor VIII deficiency – Trials in Disease Cholangitis sclerosing – Treatment Sarcoidosis – Treatment Haemophilia B with anti factor IX – Life with Disease Glycogen storage disease type II – Trials in Disease Cystic fibrosis – Diagnostics Krabbe’s disease – Life with Disease Mucopolysaccharidosis II – Trials in Disease Primary immunodeficiency syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bexotegrast Dexamethasone Acetate Sumatriptan Succinate MOLNUPIRAVIR Amniotic Membrane, Human Nemtabrutinib Nimotuzumab Tramadol Taurine Clindamycin Phosphate 4-IODOPHENYLALANINE I-131 Immunoglobulins, Normal Human Raludotatug Deruxtecan Ixazomib Citrate VIPOGLANSTAT AZD0022 Vutrisiran Sulfonamides, Urea Derivatives Loncastuximab Tesirine Cetirizine Dihydrochloride More therapies…

    Learn about Your Condition

    Thymoma malignant Meningococcal infection Exfoliation glaucoma Food allergy Ichthyosis Papillary thyroid cancer Stress Synovial sarcoma metastatic Arthralgia Small cell carcinoma Vulvovaginal discomfort Postpartum haemorrhage Pulmonary vascular disorder Peritoneal neoplasm Cardiac failure chronic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Soft tissue sarcoma

  • Study on Trabectedin and Radiotherapy for Patients with Soft Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Trabectedin
    France Italy Spain

  • Study of Selinexor and Gemcitabine for Patients with Advanced Soft-Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Gemcitabine
    • Selinexor
    Spain

  • Study on Triptorelin for Fertility Protection in Young Women and Teenagers Undergoing Chemotherapy for Breast Cancer, Leukemia, Lymphomas, and Sarcomas

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Hodgkin’s disease
    • Ewing’s sarcoma
    • Soft tissue sarcoma
    Investigated Drugs:
    • Triptorelin
    Sweden

  • Study of L-Annamycin Treatment for Patients with Previously Treated Metastatic Soft Tissue Sarcoma

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Annamycin
    Poland

  • Study on Sunitinib and Nivolumab with Chemotherapy for Patients with Advanced Soft Tissue and Bone Sarcomas

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Bone sarcoma
    • Soft tissue sarcoma
    Investigated Drugs:
    • Sunitinib
    • Nivolumab
    Italy Spain

  • Study of Cirtuvivint for Patients with Advanced Soft-Tissue Sarcomas as a Second-Line Treatment

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • CIRTUVIVINT
    Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!